ABIOMED, Inc.  

(Public, NASDAQ:ABMD)   Watch this stock  
Find more results for abmd
99.74
+0.94 (0.95%)
May 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 98.38 - 99.85
52 week 59.04 - 110.68
Open 98.81
Vol / Avg. 321,165.00/533,154.00
Mkt cap 4.24B
P/E 117.34
Div/yield     -
EPS 0.85
Shares 42.74M
Beta 1.13
Inst. own 98%
Aug 11, 2016
Abiomed Inc Annual Shareholders Meeting (Estimated) - 8:00AM EDT - Add to calendar
Aug 2, 2016
Q1 2017 Abiomed Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 3, 2016
Q4 2016 Abiomed Inc Earnings Release
May 3, 2016
Q4 2016 Abiomed Inc Earnings Call - Webcast
Mar 8, 2016
Abiomed Inc at Cowen Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2016
Net profit margin 11.71% 11.58%
Operating margin 21.09% 19.76%
EBITD margin - 20.76%
Return on average assets 10.82% 10.01%
Return on average equity 12.35% 11.55%
Employees 589 -
CDP Score - -

Address

22 CHERRY HILL DR
DANVERS, MA 01923-2575
United States - Map
+1-978-7775410 (Phone)
+1-978-7778411 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company's products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.

Officers and directors

Michael R. Minogue Chairman of the Board, President, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Tomsicek Chief Financial Officer, Vice President, Treasurer
Age: 49
Bio & Compensation  - Reuters
David M. Weber Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
William J. Bolt Senior Vice President - Global Product Operations
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Andrew J. Greenfield Vice President, General Manager - Global Marketing
Age: 42
Bio & Compensation  - Reuters
Michael G. Howley Vice President, General Manager - Global Sales and Marketing
Age: 51
Bio & Compensation  - Reuters
Ingrid Goldberg Director - Investor Relations
Bio & Compensation  - Reuters
Dorothy E. Puhy Lead Independent Director
Age: 64
Bio & Compensation  - Reuters
Jeannine M. Rivet Director
Age: 62
Bio & Compensation  - Reuters
Christopher D. Van Gorder Director
Bio & Compensation  - Reuters